Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BETAFERON for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 33 adverse event reports in the FDA FAERS database where BETAFERON was used for Relapsing-remitting multiple sclerosis.

Most Reported Side Effects for BETAFERON

Side Effect Reports % Deaths Hosp.
Multiple sclerosis relapse 102 34.5% 0 24
Multiple sclerosis 64 21.6% 0 6
Gait disturbance 19 6.4% 0 5
Hypoaesthesia 19 6.4% 0 5
Influenza like illness 15 5.1% 0 1
Drug ineffective 13 4.4% 0 2
Fatigue 13 4.4% 1 4
Pyrexia 11 3.7% 0 5
Muscular weakness 10 3.4% 0 3
Paraesthesia 10 3.4% 0 4
Headache 9 3.0% 0 5
Balance disorder 8 2.7% 0 0
Injection site reaction 8 2.7% 0 1
Abasia 7 2.4% 0 2
Asthenia 7 2.4% 1 4

Other Indications for BETAFERON

Multiple sclerosis (207) Secondary progressive multiple sclerosis (5)

Other Drugs Used for Relapsing-remitting multiple sclerosis

OCRELIZUMAB (15,658) FINGOLIMOD (8,814) OFATUMUMAB (3,864) DIMETHYL (3,638) NATALIZUMAB (2,749) INTERFERON BETA-1A (2,058) GLATIRAMER (1,965) ALEMTUZUMAB (1,604) TERIFLUNOMIDE (1,320) RITUXIMAB (956)

Related Pages

BETAFERON Full Profile All Relapsing-remitting multiple sclerosis Drugs BETAFERON Demographics BETAFERON Timeline